Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Friday reported an increase in adjusted profit for the first quarter of 2025, despite a drop in revenues.
First-quarter revenue decreased 4% annually to $52.3 billion; excluding the impact of the previously communicated large customer contract expiration, the topline grew 15%Net income attributable to the company was $416 million or $1.70 per share in Q1, vs. a loss of $12 million or $0.05 per share a year earlierOn an adjusted basis, earnings increased 9% YoY to $1.88 per share, due to higher operating earnings and a lower share count following share repurchase activityAdjusted operating earnings increased 12% to $625 million, driven by significant growth in Pharmaceutical and Specialty Solutions segment profitThe company raised its guidance for full-year earnings to the range of $7.75 per share to $7.90 per share, on an adjusted basis, from the earlier forecast of $7.55-$7.70 per share
The post Earnings Summary: Everything you need to know about Cardinal Health’s Q1 report first appeared on AlphaStreet.
—
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact [email protected]
